Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PLA | whats fair | 07/02/17 | 13 | 11K | |||
|
|||||||
PLA | Ann: Non-payment of ASX Listing Fees | 25/01/16 | 6 | 10K | |||
|
|||||||
PLA | Ann: Removal from Official List | 31/08/15 | 0 | 1.9K | |||
|
|||||||
PLA | Ann: Suspension from Official Quotation - Annual Listing Fees | 25/08/15 | 0 | 1.6K | |||
|
|||||||
PLA | Ann: Deed Administrators Update to Shareholders | 16/07/15 | 10 | 13K | |||
|
|||||||
PLA | Ann: Deed Administrator's Update to Shareholders | 09/06/15 | 0 | 1.9K | |||
|
|||||||
PLA | Ann: Resignation of Director and Appendix 3Z | 24/12/14 | 2 | 4.0K | |||
|
|||||||
PLA | ,,,,, | 04/12/14 | 2 | 3.7K | |||
|
See All Discussions